Consumer Fraud Lawyer - Lupron Marketing Litigation

Shapiro Haber & Urmy LLP served as liaison counsel in a number of consolidated actions against Abbott Laboratories, Takeda Chemical Industries LTD, and TAP Pharmaceutical Products, Inc. The cases alleged that these companies fraudulently inflated the price of the brand name drug Lupron, which is used for treatment of prostate cancer, at the expense of Medicare beneficiaries and third-party payors such as insurers. The case was settled for $150 million.